Factors Predicting Hostility in Outpatients With Schizophrenia 36-Month Results From the SOHO Study

被引:9
|
作者
Ochoa, Susana [1 ]
Suarez, David [1 ,2 ]
Novick, Diego [3 ]
Arranz, Belen [1 ]
Roca, Mercedes [1 ]
Bano, Vicente [1 ]
Maria Haro, Josep [1 ,4 ]
机构
[1] CIBERSAM, Barcelona 08830, Spain
[2] CIBERSAM, Fundacio St Joan de Deu, Barcelona 08830, Spain
[3] Eli Lilly & Co, Hlth Outcomes Res, Windlesham, Surrey, England
[4] Univ Barcelona, Fac Med, Barcelona 7, Spain
关键词
Schizophrenia; hostility; psychopathology; medication compliance; extrapyramidal effects; VIOLENT BEHAVIOR; OVERT AGGRESSION; INPATIENTS; CLOZAPINE; SYMPTOMS; RISPERIDONE; OLANZAPINE; DISORDER;
D O I
10.1097/NMD.0b013e31829480b0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This analysis explored the prevalence, incidence, and predictors of hostility in the European Schizophrenia Outpatient Health Outcomes (EU-SOHO) study. Data were collected at baseline and up to 36 months on the presence of hostility, clinical course and severity, medication compliance, side effects, substance/alcohol abuse, and being a crime survivor. Regression models were fitted to test the association between predictors and the presence of hostility. Hostility prevalence in the 6 months before baseline was 27.9%, and the incidence at 3 years was 14.0%. Variables related to hostility during follow-up were age, male sex, alcohol/substance abuse, tardive dyskinesia, extrapyramidal symptoms, cognitive impairment, noncompliance, and hospitalization. Being a crime survivor, being married, not living independently, and not being in paid employment were associated with hostility at baseline. Clinical and social variables are related to hostility in schizophrenia. Extrapyramidal symptoms and tardive dyskinesia, alcohol/substance abuse, cognitive impairment, medication noncompliance, and hospitalizations are predictors of future hostility.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 50 条
  • [21] Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
    Bitter, Istvan
    Treuer, Tamas
    Dyachkova, Yulia
    Martenyi, Ferenc
    McBride, Margaret
    Ungvari, Gabor S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (03) : 170 - 180
  • [22] Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study
    Alonso, Jordi
    Croudace, Tim
    Brown, Jacqueline
    Gasquet, Isabelle
    Knapp, Martin R. J.
    Suarez, David
    Novick, Diego
    VALUE IN HEALTH, 2009, 12 (04) : 536 - 543
  • [23] Clinical status course and quality of life after the first 2 years of treatment: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Charalambos Touloumis
    Vangelis Drossinos
    Maria Kyrana
    Kostas Ntzamaras
    Fotini Sventzouri
    Venetsanos Mavreas
    Diego Novick
    Annals of General Psychiatry, 5 (Suppl 1)
  • [24] Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
    Dossenbach, Martin
    Dyachkova, Yulia
    Pirildar, Sebnem
    Anders, Martin
    Khalil, Afaf
    Araszkiewicz, Aleksander
    Shakhnovich, Tamara
    Akram, Aly
    Pecenak, Jan
    McBride, Margaret
    Treuer, Tamas
    EUROPEAN PSYCHIATRY, 2006, 21 (04) : 251 - 258
  • [25] The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study
    Kern, Robert S.
    Gold, James M.
    Dickinson, Dwight
    Green, Michael F.
    Nuechterlein, Keith H.
    Baade, Lyle E.
    Keefe, Richard S. E.
    Mesholam-Gately, Raquelle I.
    Seidman, Larry J.
    Lee, Cathy
    Sugar, Catherine A.
    Marder, Stephen R.
    SCHIZOPHRENIA RESEARCH, 2011, 126 (1-3) : 124 - 131
  • [26] High doses of aripiprazol once-monthly in the treatment of patients with severe schizophrenia. A 36-month follow-up
    Fernandez-Miranda, J. J.
    Diaz-Fernandez, S.
    EUROPEAN PSYCHIATRY, 2020, 63 : S657 - S658
  • [27] Clinical status course and quality of life after the first 1 year of treatment: greek results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Charalambos Touloumis
    Vangelis Drossinos
    Maria Kyrana
    Kostas Ntzamaras
    Fotini Sventzouri
    Venetsanos Mavreas
    Diego Novick
    Annals of General Psychiatry, 5 (Suppl 1)
  • [28] Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions
    Szafranski, Tomasz
    PSYCHIATRIA POLSKA, 2014, 48 (06) : 1155 - 1165
  • [29] Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study
    Diego Novick
    Josep Maria Haro
    David Suarez
    Martin Lambert
    Jean-Pierre Lépine
    Dieter Naber
    Psychopharmacology, 2007, 191
  • [30] Longitudinal assessment of anxiety/depression rates and their related predictive factors in acute ischemic stroke patients A 36-month follow-up study
    Liu, Xin
    Cheng, Chunmei
    Liu, Zhaojun
    Fan, Wenjun
    Liu, Chunhua
    Liu, Yin
    MEDICINE, 2021, 100 (50) : E28022